Opinion: As states legalize recreational marijuana use for adults, they must prioritize protecting kids
Thirty-eight states and the District of Columbia have legalized the use of marijuana products for…
Category: Life Sciences
STAT+: As Washington mulls new AI rules, startup leaders want a seat at the table
WASHINGTON — In San Francisco, Y Combinator’s firebrand chief executive Garry Tan is one of…
These are the bird flu questions that influenza and animal scientists desperately want answered
Ten weeks after government scientists discovered that H5N1 bird flu was sickening dairy cattle in…
CDC endorses prophylactic antibiotics to reduce STIs in high-risk groups
The Centers for Disease Control and Prevention finalized its guidelines for post-exposure prophylaxis against bacterial…
ASCO Takeaways: Winners, snoozers, the China question and the art of cancer care
You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American…
Senators tussle over abortion policy against the backdrop of a presidential campaign
WASHINGTON — Nearly two years after the Supreme Court overturned Roe v. Wade, U.S. senators on…
.jpg)
STAT+: U.S. drug shortages have reached a decade high and are lasting longer, too
Amid rising concern over prescription drug shortages, a new report finds that the number of…
STAT+: Medicare Advantage plan’s quality ratings were incorrectly calculated by government, judge rules
The federal government inappropriately lowered the 2024 Medicare Advantage star ratings of SCAN Health Plan,…
Operation Warp Speed but for rare disease
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about an FDA meeting on MDMA, a new obesity pill, and more
Top of the morning to you, and a fine one it is. There is nothing…
Opinion: Outdated Medicare rules prevent some dementia patients from getting the medications they need
Memory loss is the most obvious symptom of Alzheimer’s disease. But for the more than…
STAT+: Novartis is flashing warning signs about the fate of its newly acquired myelofibrosis drug
CHICAGO — Something is off about the way Novartis is talking about pelabresib, its newly…
A new discovery about carbon dioxide is challenging decades-old ventilation doctrine
Carbon dioxide monitors have been around for decades. But in 2020, they became, almost overnight,…
STAT+: Tracking the FDA advisory panel on MDMA therapy for PTSD
Good morning, and welcome to STAT’s live blog of the Food and Drug Administration’s scientific…
STAT+: How a device maker inundated pain patients with unwanted batteries and surprise bills
Michelle Bean is drowning in batteries she doesn’t need. For two years, the batteries and…
.jpg)
5 takeaways from STAT’s look at unwanted supplies and surprise bills from device maker Zynex Medical
Sending patients heaps of medical supplies to score more money from insurers is common in…
Battling Against a Sweet Tooth? 6 Natural Sugar Alternatives With Health Benefits – CNET
Battling Against a Sweet Tooth? 6 Natural Sugar Alternatives With Health Benefits CNET Read Original Article:…
STAT+: Illumina board agrees to spin off Grail, as divestment plans proceed
Illumina said Monday afternoon that its board of directors had approved a spin-off of its…
STAT+: ASCO Daily Recap: A CAR-T advance, money talk, and tossing the cancer treatment ‘sandwich’
You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American…
STAT+: Leading CRO to pay record fine for badly neglecting hundreds of beagles in breeding facility
A leading contract research organization has agreed to pay $35 million — including the largest-ever…
STAT+: At ASCO, AstraZeneca says its CAR-T therapy shrank solid liver tumors in early trial
CHICAGO — A next-generation CAR-T therapy was able to substantially shrink tumors in patients with…
Anthony Fauci, facing GOP accusers, says debate on Covid origins has been ‘seriously distorted’
WASHINGTON — Anthony Fauci, the former top U.S. infectious disease official and a longtime foil…
STAT+: Becton Dickinson to buy Edwards patient monitoring unit for $4.2 billion
Becton Dickinson plans to pay $4.2 billion for Edwards Lifesciences’ critical care business, which sells…
STAT+: A short-lived Medicaid freakout sends insurers’ stocks diving
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Pharmalittle: We’re reading about Zantac lawsuits, worries over MDMA for PTSD, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Can AstraZeneca make good on its promise?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Delfi Diagnostics announces key data, study design for its liquid biopsy test
CHICAGO — Delfi Diagnostics, a company seeking to develop liquid biopsy tests to help screen…
STAT+: Structure Therapeutics oral GLP-1 drug led to weight loss in two studies
Structure Therapeutics reported Monday that its oral GLP-1 drug led to weight loss in two…
STAT+: Agios drug reduces blood transfusions in patients with beta-thalassemia, study shows
Agios Pharmaceuticals said Monday that its drug called mitapivat reduced the need for blood transfusions…
STAT+: Elevance PBM’s president out as customers complain of prescription chaos
Paul Marchetti, the head of insurer Elevance Health’s pharmacy benefit manager, has left the company…
Study finds BMI, despite flaws, is useful estimate of body fat in children
The body mass index has long been slammed as a blunt instrument for evaluating health,…
STAT+: Intellia’s CRISPR-based treatment dramatically reduced patients’ swelling attacks in small trial
Intellia Therapeutics said Saturday that the first 10 patients to receive a CRISPR-based treatment for…
STAT+: ASCO Daily Recap: AstraZeneca’s hat trick, a GSK turnaround, and palliative care as telehealth
You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American…
Palliative care for cancer patients is found to be as effective given virtually as in person
CHICAGO — Comfort can be delivered to patients with advanced cancer virtually just as well…
STAT+: AstraZeneca’s Tagrisso greatly slows cancer for some people with stage 3 lung cancer
In patients with stage 3 lung cancer where a particular genetic mutation is present in…
STAT+: With new results at ASCO, Enhertu once again rewrites rules of breast cancer treatment
CHICAGO — The cancer drug Enhertu stalled the growth of tumors by more than a…
STAT+: ASCO 2024: Data put a new shine on GSK blood cancer drug that was pulled from market
LONDON — The resurrection of a GSK blood cancer drug — which the company withdrew…
STAT+: ASCO Daily Recap: Safety data for Novartis myelofibrosis candidate, survival data for Pfizer drug
You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American…
STAT+: At ASCO, pharma leaders explain how ‘smart bomb’ drugs became useful against more cancers
CHICAGO — The ways clinicians can treat cancers effectively are expanding, partly because technologies today…
STAT+: ASCO 2024: FDA oncology head wants clinical trials to range beyond China alone
CHICAGO — The Food and Drug Administration’s top oncologist reiterated that the agency doesn’t want drugmakers…
STAT+: With expectations rising, Corbus reveals new data on its ADC bladder cancer treatment
CHICAGO — Corbus Pharmaceuticals is the second best-performing biotech stock this year, thanks to investor…
How can hospitals boost cancer screening rates? Researchers report that an AI helped
CHICAGO — People can be mightily reluctant to get a colonoscopy for reasons like cost,…
Opinion: Readers respond to essays on young caregivers, digital health, and more
To encourage robust, good-faith discussion about issues raised in First Opinion, STAT publishes selected Letters…
STAT+: HHS: Change Healthcare can make data breach notifications in lieu of hospitals
Change Healthcare can notify patients whose sensitive health information has been exposed as a result…
What to watch for in the crucial FDA meeting on MDMA therapy for PTSD
In less than three months, the Food and Drug Administration will decide whether to approve…
Woman is back on dialysis after doctors remove transplanted pig kidney
WASHINGTON — A woman who received a pig kidney transplant is back on dialysis just 47…
FDA approves Moderna’s RSV vaccine, its second licensed product
The Food and Drug Administration on Friday approved Moderna’s vaccine to protect older adults against…
STAT+: Pharmalittle: We’re reading about docs paid for endorsements, Novartis suing Maryland, and lots more
And so, another working week will soon draw to a close. Not a moment too…
The surprising outperformance of a new drug against existing competitors, and other biotech updates
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Ionis drug prevents swelling attacks caused by rare genetic disease in late-stage trials
Ionis Pharmaceuticals, a California company that pioneered a whole class of RNA-targeted medicines, reported on…